Clinical Trial Update: Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating allogeneic umbilical cord mesenchymal stem cell therapy for autism has completed. Sponsor is Translational Biosciences.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy

Snippet

Sponsor: Translational Biosciences | Conditions: Autism | Phase 1, Phase 2 | Status: COMPLETED